Filters

Preprints

2025

2024

Mantas I, Contestabile A, Skara V, Loiseau C, Santos IA, Cramb KML, Filograna R, Wade-Martins R, Magill PJ, Meletis K

Anxa1+ dopamine neuron vulnerability defines prodromal Parkinson’s disease bradykinesia and procedural motor learning impairment

10.1101/2024.12.22.629963
Andrews R, Fu B, Toomey CE, Breiter JC, Lachica J, Tian R, Beckwith JS, Needham L, Chant GJ, Loiseau C, Deconfin A, Baspin K, Magill PJ, Jaunmuktane Z, Freeman OJ, Taylor BJ, Hardy J, Lashley T, Ryten M, Vendruscolo M, Wood NW, Weiss LE, Gandhi S, Lee SF

Large-scale visualisation of α-synuclein oligomers in Parkinson's disease brain tissue

10.1101/2024.02.17.580698

2023

Gullino LS, Fuller C, Dunn P, Collins HM, El Mestikawy S, Sharp T

Evidence for a role of 5-HT-glutamate co-releasing neurons in acute stress mechanisms

10.1101/2023.11.25.568634
Collins HM, Gullino LS, Ozdemir D, Lazarenco C, Sudarikova Y, Daly E, Cuéllar FP, Pinacho R, Bannerman DM, Sharp T

Rebound activation of 5-HT neurons following SSRI discontinuation

10.1101/2023.09.23.558888

2022

Wiest C, Torrecillos F, Pogosyan A, Bange M, Muthuraman M, Groppa S, Hulse N, Hasegawa H, Ashkan K, Baig F, Morgante F, Pereira EA, Mallet N, Magill PJ, Brown P, Sharott A, Tan H

The aperiodic exponent of subthalamic field potentials reflects excitation/inhibition balance in Parkinsonism: a cross-species study in vivo

10.1101/2022.08.23.504923
Avvisati R, Kaufmann AK, Young CJ, Portlock GE, Cancemi S, Costa RP, Magill PJ, Dodson PD

Distributional coding of associative learning within projection-defined populations of midbrain dopamine neurons

10.1101/2022.07.18.500429

2021